Drugs / Ezetimibe/simvastatin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01587235 | Mar 2013 → May 2014 | hyperlipidemia | Organon and Co | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ezetimibe/simvastatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01587235 ↗ |
| Known as | MK-0653 | “This study will evaluate and compare the effectiveness of MK-0653 (Vytorin) to current standard treatment with other statins for the treatment of dyslipidemia in moderate,...” NCT01587235 ↗ |
| Route | Oral | “orally once daily” NCT01587235 ↗ |